Institutional Ownership
Context Therapeutics Inc
CUSIP 21077P108COMCNTXQ1 2026
13D / 13G Filings
36
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
16.4%
Max % of class reported
Institutional Holders
56
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
36 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Mpm Bioimpact LLC | 13G/A | 11.6% | 10.68M | SEC |
| 2 | Feb 17, 2026 | Great Point Partners, LLC | 13G/A | 5.1% | 4.68M | SEC |
| 3 | Feb 3, 2026 | Soleus Capital Master Fund, L.P. | 13G | 5.2% | 4.78M | SEC |
| 4 | Nov 14, 2025 | Great Point Partners, LLC | 13G/A | 5.2% | 4.68M | SEC |
| 5 | Nov 14, 2025 | Avidity Partners Management LP | 13G/A | 9.9% | — | SEC |
| 6 | Aug 14, 2025 | Great Point Partners, LLC | 13G/A | 5.2% | 4.68M | SEC |
| 7 | Aug 14, 2025 | Avidity Partners Management LP | 13G/A | 9.9% | — | SEC |
| 8 | May 15, 2025 | Great Point Partners, LLC | 13G/A | 5.2% | 4.68M | SEC |
| 9 | May 15, 2025 | Deep Track Capital, LP | 13G/A | 8.3% | 7.42M | SEC |
| 10 | May 9, 2025 | Franklin Resources, Inc. | 13G/A | 4.5% | 4.00M | SEC |
26 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Context Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Mpm Bioimpact LLC | 10.68M | $27.98M |
| 2 | Nextech Invest, Ltd. | 7.42M | $19.44M |
| 3 | Deep Track Capital, LP | 7.42M | $19.44M |
| 4 | Soleus Capital Management, L.P. | 6.96M | $18.24M |
| 5 | Octagon Capital Advisors LP | 5.25M | $13.76M |
| 6 | Blue Owl Capital Holdings LP | 5.09M | $13.33M |
| 7 | Avidity Partners Management LP | 5.00M | $13.10M |
| 8 | Franklin Resources Inc | 3.80M | $9.96M |
| 9 | Marshall Wace, LLP | 2.95M | $7.72M |
| 10 | Tcg Crossover Management, LLC | 2.68M | $7.03M |